On January 20th, Livzon Pharma spent approximately 9.9981 million yuan to repurchase 274,900 A-shares.

date
20/01/2025
avatar
GMT Eight
LIVZON PHARMA (01513) announced that it will purchase approximately 27.49 million A-shares for about 9.9981 million yuan on January 20, 2025.
pre
YEE HOP HLDGS (01662) trading unit will be changed to 1000 shares per lot.
Hangzhou Alltest Biotech (688606.SH) released a pre-increase forecast, with an expected net profit of 278 million to 298 million yuan in 2024, a year-on-year increase of 53.95% to 65.03%.
next

RECOMMEND

recommend

OCUMENSION-B(01477) issued 1.319 million shares.

date
8 min ago
recommend

KINGMAKER (01170) repurchased 200,000 shares for HKD 126,000 on January 20.

date
8 min ago
recommend

EU plans to push for "fluoride restriction order" to ban the use of PFAS substances in consumer products.

date
8 min ago

©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.

Contact: contact@gmteight.com